Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Little Sparrows Technologies is a private neonatal medical device company focused on improving newborn care, especially treatment of neonatal jaundice. Its lead commercial product is bili-hut, an FDA-cleared portable phototherapy system designed to deliver high-intensity blue-light treatment for infant jaundice in hospitals and at home. The company also markets bili-ruler, a prescription jaundice screening tool, and has expanded into related developmental-care accessories for newborns. Founded by physicians affiliated with Harvard Medical School, Little Sparrows emphasizes family-centered, portable, and globally deployable neonatal technologies, including products tailored for low-resource settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Little Sparrows Technologies.